Ado trastuzumab emtansine, also known as T-DM1, is an innovative drug used in the treatment of HER2-positive breast cancer. It is a type of antibody-drug conjugate (ADC) that combines the HER2-targeting properties of trastuzumab (Herceptin) with the cytotoxic activity of a chemotherapy agent called DM1.
